|
SFRS13A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.432150E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.778500E-02 |
| Normal-vs-Stage2 |
1.975200E-01 |
| Normal-vs-Stage3 |
1.090650E-01 |
| Normal-vs-Stage4 |
2.913800E-01 |
| Stage1-vs-Stage2 |
8.859800E-01 |
| Stage1-vs-Stage3 |
9.555400E-01 |
| Stage1-vs-Stage4 |
9.182400E-01 |
| Stage2-vs-Stage3 |
8.578600E-01 |
| Stage2-vs-Stage4 |
9.973000E-01 |
| Stage3-vs-Stage4 |
8.884000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.701990E-01 |
| Normal-vs-AfricanAmerican |
7.010400E-02 |
| Normal-vs-Asian |
5.665200E-01 |
| Caucasian-vs-AfricanAmerican |
5.526200E-01 |
| Caucasian-vs-Asian |
8.682800E-01 |
| AfricanAmerican-vs-Asian |
6.823800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.056560E-01 |
| Normal-vs-Female |
3.593200E-01 |
| Male-vs-Female |
4.050000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.087600E-02 |
| Normal-vs-Extreme_Weight |
5.381800E-02 |
| Normal-vs-Obese |
1.625640E-01 |
| Normal-vs-Extreme_Obese |
1.034380E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.701400E-01 |
| Normal_Weight-vs-Obese |
5.190200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.121600E-01 |
| Extreme_Weight-vs-Obese |
4.877000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.951000E-01 |
| Obese-vs-Extreme_Obese |
5.267800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.042400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.927600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.814500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.007840E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.987400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.278100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.338300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.428300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.816100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.769400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.692000E-01 |
| Normal-VS-Type2 PRCC |
1.723640E-03 |
| Normal-VS-KIRP CIMP |
1.011250E-01 |
| Normal-VS-Unclassified PRCC |
7.672200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.012700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.274200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.147800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.403200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.496100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.830400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.032230E-02 |
| Normal-vs-N1 |
4.561200E-01 |
| Normal-vs-N2 |
2.826300E-02 |
| N0-vs-N1 |
1.699750E-01 |
| N0-vs-N2 |
2.318000E-01 |
| N1-vs-N2 |
1.358810E-01 |
|
|
